** Shares of WuXi Biologics (Cayman) Inc 2269.HK jump 4.9% to HK$30.15, their highest since January 2024, and on course for a third consecutive session of gains
** Stock set for the biggest one-day pct gain since June 9, if current gains hold
** Co expects H1 revenue to increase 16% y/y, profit attributable to equity shareholders to rise 56% and gross profit margin to expand 3.6%
** The Hang Seng Biotech Index .HSHKBIO rises 1.1%, the benchmark Hang Seng Index .HSI adds 0.7%
** YTD, stock up 70.6%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.